Breaking News

Why doesn’t the U.S. have at-home flu tests?; a simple screening could help millions of women prevent heart disease

  

 

Daily Recap

Why doesn't the U.S. have at-home flu tests?

By Brittany Trang

NIAID

No at-home flu tests are available for purchase in the U.S. That's not for lack of technology.

Read More

Real-world data show updated Covid-19 boosters increase protection against infection

By Andrew Joseph

Steve Helber/AP

The protection was even stronger when people waited a longer period of time since their last dose of the original Covid shot.

Read More

STAT+: 'Digital health is late to the party': Can telehealth help curb mitigate their carbon footprints?

By Katie Palmer

Adobe

Telehealth has been held up as a prime strategy to cut down on carbon emissions from the health care systems. But it comes with trade-offs.

Read More

A simple screening question could help millions of women prevent cardiovascular disease. Why aren't we using it?

By Katherine Harmon Courage

Jovelle Tamayo for STAT

Data on pregnancy complications such as preeclampsia are missing from standard cardiovascular disease risk calculators.

Read More

One-third of U.S. labs have stopped using race-based equations to diagnose kidney disease

By Brittany Trang

Adobe

A growing movement in medicine argues that race-based equations aren't accurate—and they can be actively harmful.

Read More

U.K. analysis shows one dose of monkeypox vaccine yields strong protection

By Andrew Joseph

Hollie Adams/Getty Images

Researchers estimated that one monkeypox vaccine dose was 78% effective at protecting against infection 14 or more days after vaccination.

Read More

Opinion: A tripledemic hurricane is making landfall. We need masks, not just tent hospitals

By Anne N. Sosin and Lakshmi Ganapathi and Martha Lincoln

Chandan Khanna/Getty

The viral tripledemic should demand crisis clinical measures as well as community prevention efforts. Why are the latter being abandoned?

Read More

STAT+: GSK to withdraw blood cancer drug from U.S. market following confirmatory study setback

By Adam Feuerstein

Kirsty Wigglesworth/AP

The decision on the drug, which secured accelerated in 2020, follows a request from the Food and Drug Administration

Read More

Tuesday, November 22, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments